MIT Technology Review September 26, 2024
Plus: OpenAI wants to become a for-profit
This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology.
Two Nobel Prize winners want to cancel their own CRISPR patents in Europe
In the decade-long fight to control CRISPR, the super-tool for modifying DNA, it’s been common for lawyers to try to overturn patents held by competitors. But now, in a surprise twist, the team that earned the Nobel Prize in chemistry for developing CRISPR is asking to cancel two of their own seminal patents, MIT Technology Review has learned.
The request to withdraw the pair of European patents, by lawyers for Emmanuelle Charpentier and Jennifer Doudna, comes...